Rocket Pharmaceuticals
RCKT
RCKT
224 hedge funds and large institutions have $1.38B invested in Rocket Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 97 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $2.28M
19% less capital invested
Capital invested by funds: $1.71B → $1.38B (-$328M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
224
Holding in Top 10
3
Calls
$2.08M
Puts
$2.28M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$32.3M | |
| 3 | +$26.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$24.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.1M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$11.5M | |
| 3 | -$10.9M | |
| 4 |
BAMCO Inc
New York
|
-$10.2M |
| 5 |
PA
Perceptive Advisors
New York
|
-$6.95M |